Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 583.5 | 464.7 | 339.9 | 385.2 | 0.1 | 239.1 | 146.2 |
| Revenue growth | 25.6% | 36.7% | -11.8% | 447767.4% | -100.0% | 63.5% | |
| Cost of goods sold | 299.4 | 244.0 | 192.8 | 217.3 | 257.4 | 145.4 | 93.6 |
| Gross profit | 284.1 | 220.7 | 147.1 | 167.8 | -257.3 | 93.7 | 52.7 |
| Gross margin | 48.7% | 47.5% | 43.3% | 43.6% | -299231.4% | 39.2% | 36.0% |
| Selling, general and administrative | 60.4 | 80.6 | 51.9 | 38.8 | 27.7 | 13.1 | 6.6 |
| Research and development | 134.4 | 128.7 | 102.4 | 92.0 | 75.7 | 38.6 | 28.5 |
| EBIT | 89.3 | 11.4 | -7.2 | 37.0 | 117.6 | 41.9 | 17.6 |
| EBIT margin | 15.3% | 2.5% | -2.1% | 9.6% | 136761.6% | 17.5% | 12.0% |
| Pre-tax income | 94.8 | 21.6 | -0.4 | 40.3 | 114.6 | 39.8 | 16.5 |
| Income taxes | 4.5 | -11.2 | -5.3 | 1.8 | -17.0 | -0.7 | 2.9 |
| Tax rate | 4.7% | | 1316.8% | 4.5% | | | 17.8% |
| Net income | 90.4 | 32.8 | 4.9 | 38.5 | 95.3 | 7.6 | 1.7 |
| Net margin | 15.5% | 7.1% | 1.4% | 10.0% | 110795.3% | 3.2% | 1.2% |
| |
| Diluted EPS | $2.09 | $0.77 | $0.12 | $0.92 | $3.22 | $0.91 | $0.23 |
| Shares outstanding (diluted) | 43.2 | 42.6 | 42.0 | 41.7 | 29.6 | 8.3 | 7.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|